Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114436183 | 11443618 | 3 | F | 20130715 | 20160826 | 20150901 | 20160826 | EXP | JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-022763 | BRISTOL MYERS SQUIBB | 70.00 | YR | M | Y | 68.00000 | KG | 20160826 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114436183 | 11443618 | 1 | PS | SPRYCEL | DASATINIB | 1 | Oral | 70 MG, BID | 3920 | MG | Y | 21986 | 70 | MG | BID | ||||
| 114436183 | 11443618 | 2 | SS | SPRYCEL | DASATINIB | 1 | Oral | 50 MG, BID | 3920 | MG | Y | 21986 | 50 | MG | BID | ||||
| 114436183 | 11443618 | 3 | C | ALLELOCK | OLOPATADINE HYDROCHLORIDE | 1 | Oral | 5 MG, BID | U | 0 | 5 | MG | BID | ||||||
| 114436183 | 11443618 | 4 | C | AMARYL | GLIMEPIRIDE | 1 | Oral | 1 MG, QD | U | 0 | 1 | MG | QD | ||||||
| 114436183 | 11443618 | 5 | C | AMARYL | GLIMEPIRIDE | 1 | Oral | 100 MG, QD | U | 0 | 100 | MG | QD | ||||||
| 114436183 | 11443618 | 6 | C | METGLUCO | METFORMIN HYDROCHLORIDE | 1 | Oral | 250 MG, TID | U | 0 | 250 | MG | TID | ||||||
| 114436183 | 11443618 | 7 | C | LYRICA | PREGABALIN | 1 | Oral | 150 MG, QD | U | 0 | 150 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 114436183 | 11443618 | 1 | Chronic myeloid leukaemia |
| 114436183 | 11443618 | 3 | Product used for unknown indication |
| 114436183 | 11443618 | 4 | Product used for unknown indication |
| 114436183 | 11443618 | 6 | Product used for unknown indication |
| 114436183 | 11443618 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 114436183 | 11443618 | OT |
| 114436183 | 11443618 | LT |
| 114436183 | 11443618 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 114436183 | 11443618 | Pleural effusion | |
| 114436183 | 11443618 | Respiratory failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 114436183 | 11443618 | 1 | 20130618 | 20140812 | 0 | |
| 114436183 | 11443618 | 2 | 20130718 | 20140812 | 0 | |
| 114436183 | 11443618 | 3 | 20131217 | 0 | ||
| 114436183 | 11443618 | 4 | 20130727 | 0 | ||
| 114436183 | 11443618 | 5 | 20130618 | 0 | ||
| 114436183 | 11443618 | 6 | 20130727 | 0 | ||
| 114436183 | 11443618 | 7 | 20130906 | 0 |